On the design of a bacterial cell-based prodrug enzyme system for HER2 positive breast cancer:
<p>There are over 50,000 new cases of breast cancer a year in the UK alone, and the HER2+ subtype, an especially aggressive form of the disease, poses significant challenges. In this thesis, the cytotoxic function of a bacterial system to treat HER2+ breast cancer is developed and explored. Th...
| Päätekijä: | |
|---|---|
| Muut tekijät: | |
| Aineistotyyppi: | Opinnäyte |
| Kieli: | English |
| Julkaistu: |
2023
|
| Aiheet: |